FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Nephron Sterile Compounding Center PF-Neostigmine Methylsulfate Injection Recall

PF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose Vi…

Nephron Sterile Compounding Center LLC · West Columbia, SC

Risk level
Class II
Reported by FDA
Aug 24, 2022
Recall ID
D-1344-2022
Check your lot numberHow we source this data

Summary

Nephron Sterile Compounding Center recalled PF-Neostigmine Methylsulfate Injection starting Aug 10, 2022. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-1344-2022 on Aug 24, 2022. Reason: CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing. Status: Terminated.

Why it was recalled

CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.

Product description

PF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose Vial, packaged in 30 x 3 mL Sterile Unit-Dose Vials per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th Street Extension, West Columbia, SC 29172; NDC 69374-932-33

Lot numbers, UPCs & expiration codes

Lot: NE1057A, Exp. 10/23/2022

Where it was sold

Nationwide in the USA

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-1344-2022
Classification
Class II
Status
Terminated
Recall initiated
Aug 10, 2022
FDA report date
Aug 24, 2022
Quantity
13,500 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Nephron Sterile Compounding Center LLC

Original FDA data

Every field from FDA enforcement report D-1344-2022, exactly as published.

Show all FDA fields
City
West Columbia
State
SC
Status
Terminated
Country
United States
Event ID
90718
Address
4500 12th Street Ext
Code information
Lot: NE1057A, Exp. 10/23/2022
Postal code
29172-3025
Report date
Aug 24, 2022
Product type
Drugs
Recall number
D-1344-2022
Classification
Class II
Recalling firm
Nephron Sterile Compounding Center LLC
Product quantity
13,500 vials
Termination date
Oct 11, 2024
Reason for recall
CGMP Deviations: Potential for cross-contamination due to product carryover during manufacturing.
Voluntary / mandated
Voluntary: Firm initiated
Product description
PF-Neostigmine Methylsulfate Injection, USP, 3 mg/3 mL (1 mg/mL), One 3 mL Unit-Dose Vial, packaged in 30 x 3 mL Sterile Unit-Dose Vials per carton, Rx Only, Nephron 503B Outsourcing Facility, 4500 12th Street Extension, West Columbia, SC 29172; NDC 69374-932-33
Distribution pattern
Nationwide in the USA
Recall initiation date
Aug 10, 2022
Initial firm notification
Letter
Center classification date
Aug 16, 2022

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-1344-2022, published Aug 24, 2022. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls